Clinical Use of β2-adrenergic Receptor Agonists Based on Their Intrinsic Efficacy
Clinical choice of β2-adrenergic receptor agonists (β2-agonists) is based on the parameter of receptor selectivity, potency, and duration of action. The guidelines for asthma management describe nothing about intrinsic efficacy concerning the use of β2-agonists. Since intrinsic efficacy refers to th...
Main Author: | Hiroaki Kume |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2005-01-01
|
Series: | Allergology International |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1323893015310108 |
Similar Items
-
Long-acting β2-adrenergic receptor agonist in pediatric asthma
by: Shigemi Yoshihara, et al.
Published: (2004-01-01) -
Role of Sphingosine-1-Phosphate in β-adrenoceptor Desensitization via Ca2+ Sensitization in Airway Smooth Muscle
by: Yasushi Makino, et al.
Published: (2012-01-01) -
Involvement of reduced sensitivity to Ca2+ in b-adrenergic action on airway smooth muscle
by: Oguma, Tetsuya, et al.
Published: (2006) -
Beta-Adrenergic Receptors and Mechanisms in Asthma: The New Long-Acting Beta-Agonists
by: Robert G Townley
Published: (1996-01-01) -
Beta-Adrenergic Agonists
by: Giovanni Barisione, et al.
Published: (2010-03-01)